BridgeMD
New treatment option for Rotator Cuff Related Shoulder Pain
Official title The Effect of an Exercise Program Based on Attentional Focus Shifting on Clinical Outcomes in Rotator Cuff Related Shoulder Pain
ClinicalTrials.gov ID: NCT07546084
What this study is testing
- What it's testing
- The aim of this clinical trial is to investigate the effects of an attention shift-based rehabilitation program on clinical outcomes in individuals with rotator cuff-related shoulder pain (RCRSP). The study will evaluate the effects of an attention shift approach, in which motor tasks targeting regions outside the shoulder are performed concurrently with standard shoulder exercises, on pain, functional status, and pain catastrophizing.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Having symptoms persisting for at least 3 months
- Experiencing pain intensity of at least 3 on the Numeric Pain Rating Scale (NPRS) during activity
- Presence of a painful arc during shoulder flexion or abduction
- Positive Neer test or Hawkins-Kennedy test
- Pain provoked by resisted external rotation/abduction of the humerus, or a positive Jobe (Empty Can) test
You likely can't join if
- Presence of adhesive capsulitis (≥30% limitation in passive range of motion)
- Advanced osteoarthritis of the shoulder
- History of fracture or dislocation affecting the shoulder region
- Advanced acromioclavicular joint pathology
- Massive rotator cuff tear (positive lag signs)
- Previous shoulder surgery
See the full eligibility criteria
- Having symptoms persisting for at least 3 months
- Experiencing pain intensity of at least 3 on the Numeric Pain Rating Scale (NPRS) during activity
- Presence of a painful arc during shoulder flexion or abduction
- Positive Neer test or Hawkins-Kennedy test
- Pain provoked by resisted external rotation/abduction of the humerus, or a positive Jobe (Empty Can) test
- Having a clinical diagnosis of subacromial pain syndrome, rotator cuff tendinopathy, subacromial bursitis, or symptomatic partial/full-thickness rotator cuff tear
- Being able to understand and complete questionnaires in Turkish
- Presence of adhesive capsulitis (≥30% limitation in passive range of motion)
- Advanced osteoarthritis of the shoulder
- History of fracture or dislocation affecting the shoulder region
- Advanced acromioclavicular joint pathology
- Massive rotator cuff tear (positive lag signs)
- Previous shoulder surgery
- Presence of neurological disorders
- Diagnosis of rheumatoid arthritis
- History of cancer
- Symptomatic cervical spine pathology
- Corticosteroid injection to the shoulder within the past 6 weeks
- Cognitive impairments that may interfere with the ability to perform clinical tasks or execute attention shift-based exercises
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.